Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1821292012
Clinic

San Michael Pediatrics INC

San Michael Pediatrics INC was paid $6.46M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.

33Billing provider infoSAN MICHAEL PEDIATRICS INC
BAKERSFIELD, CA 93308
33aNPI1821292012assigned 06/12/2007
28Total paid$6.46M
24GClaims216,469
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Primary Care Clinic/Center providers in California

Rank by total paid#18 of 422
Median peer was paid$25K
This provider vs. median263×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,355$597K
201930,354$729K
202027,349$672K
202132,661$873K
202234,010$940K
202331,962$902K
2024incomplete34,778$1.75M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 50% 74,564 50,491 $3.24M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.5% 6,935 6,896 $421K
G9920 Screening performed and negative 5.9% 10,864 10,801 $381K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 5.5% 6,368 6,316 $357K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.9% 4,154 4,137 $316K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.2% 4,008 3,846 $204K
99188 2.9% 9,323 9,228 $189K
92551 2.7% 14,506 14,410 $177K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2.6% 2,437 2,414 $171K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.2% 3,527 3,256 $140K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.1% 1,687 1,664 $134K
90649 1.4% 469 467 $88K
48 more codes
99173 <1% 14,423 $65K
90686 <1% 5,128 $52K
90700 <1% 4,230 $46K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,636 $39K
90670 <1% 3,156 $34K
90713 <1% 3,140 $34K
G8431 Screening for depression is documented as being positive and a follow-up plan is documented <1% 961 $32K
85018 <1% 14,582 $27K
90648 <1% 2,436 $27K
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 2,003 $26K
D1206 Topical application of fluoride varnish <1% 1,137 $25K
90716 <1% 2,164 $23K
90633 <1% 2,055 $22K
90707 <1% 2,046 $22K
90744 <1% 1,849 $20K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 639 $20K
90680 <1% 1,678 $18K
90651 <1% 1,670 $17K
99214 Doctor's office visit, returning patient (more involved) <1% 309 $12K
90621 <1% 606 $11K
90715 <1% 1,033 $11K
90734 <1% 989 $10K
90619 <1% 737 $8K
99381 <1% 83 $8K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 1,539 $5K
90698 <1% 458 $5K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 2,484 $4K
90677 <1% 329 $4K
99383 <1% 25 $3K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 25 $3K
83655 <1% 241 $3K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 204 $1K
97802 <1% 1,413 $1K
G9919 Screening performed and positive and provision of recommendations <1% 38 $1K
99442 <1% 36 $1K
90658 <1% 108 $1K
90660 <1% 116 $1K
J7612 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg <1% 107 $727.94
90657 <1% 45 $555.72
90655 <1% 42 $472.50
86580 <1% 70 $235.20
90647 <1% 16 $168.75
4004F <1% 277 $156.78
81001 <1% 74 $156.64
90710 <1% 12 $56.25
0001A 0% 13 $0.00
3008F 0% 249 $0.00
0002A 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHAFIC, EMAD (OFFICER)